On-Demand Content | Virtual Event

The momentum towards providing safe and affordable access to psychedelics and empathogens for therapeutic relief from behavioral health issues continues to build and inspire shifting regulations, increasing investment and what might eventually become a bubble of emerging entrepreneurial ventures.

Join us at The Second Psychedelic Opportunity Summit taking place June 22nd, 2021 via a Virtual Event Platform to gain the knowledge and connections needed to tap into the therapies and applications driving this exploding market.

THE FOUNDER’S MISSION

I founded the Psychedelic Opportunity Summit in 2020 because as someone who battled depression, anxiety, and PTSD for much of my life, I was finally saved by MDMA therapy, and wanted to do my part to support the responsible growth of this industry and provide a way to help many who still suffer, like I did.

Ben Greenzweig

CEO, Co-Founder, Momentum Events

SPEAKERS HIGHLIGHTS

Benton Bodamer
Benton Bodamer
Member

DICKINSON WRIGHT

Hilary Bricken
Hilary Bricken
Attorney

HARRIS BRICKEN

Nicole Buchanan
Nicole Buchanan
Professor of Psychology

MICHIGAN STATE UNIVERSITY

Mackenzie Bullard
Mackenzie Bullard
Community Engagement Facilitator

BOSTON MEDICAL CENTER

Daniel Carcillo
Daniel Carcillo
Former NHL Player, Founder & CEO

WESANA HEALTH

Sam Chapman
Sam Chapman
Executive Director

THE HEALING ADVOCACY FUND

Alex Dominguez
Alex Dominguez
State Representative

STATE OF TEXAS

Amanda Eilian
Amanda Eilian
Co-Founder

ABLE PARTNERS

Ben Greenzweig
Ben Greenzweig
CEO

MOMENTUM EVENTS

Ifetayo Harvey
Ifetayo Harvey
Founder

PEOPLE OF COLOR PSYCHEDELIC COLLECTIVE

Stephen Hays
Stephen Hays
Founder

WHAT IF VENTURES

Lucia Huang
Lucia Huang
Co-Founder & CEO

OSMIND

Holly Jacobus
Holly Jacobus
Investment Partner

JOYANCE & SOCIAL STARTS

Ronan Levy
Ronan Levy
Executive Chairman

FIELD TRIP HEALTH LTD.

Benjamin Lightburn
Benjamin Lightburn
CEO and Co-Founder

FILAMENT HEALTH

Mason Marks, MD
Mason Marks, MD
Attorney

HARRIS BRICKEN

Greg McKee
Greg McKee
Chairman and CEO

TRYP THERAPEUTICS

Joe Moore
Joe Moore
Co-Founder

PSYCHEDELICS TODAY

Lynn Marie Morski, M.D., JD
Lynn Marie Morski, M.D., JD
President

PSYCHEDELIC MEDICINE ASSOCIATION

Danny Motyka
Danny Motyka
Chief Executive Officer

PSYGEN INDUSTRIES LTD.

Owen Muir MD
Owen Muir MD
Chief Innovation Officer

BROOKLYN MINDS

Jon Purow
Jon Purow
Counsel

ZUBER LAWLER

Tim Schlidt
Tim Schlidt
Co-Founder & Partner

PALO SANTO

Kathryn Tucker
Kathryn Tucker
Co-Chair Psychedelic Practice, Emerge Law Group, and Founding Member

PSYCHEDELIC BAR ASSOCIATION

Joseph Tucker, MD
Joseph Tucker, MD
President & CEO

MAGICMED

Nadia Van der Heyden
Nadia Van der Heyden
Director of Sales and Marketing

PSYGEN INDUSTRIES LTD.

Sonia Weiss
Sonia Weiss
General Partner

WPSS INVESTMENTS

Nolan Williams MD
Nolan Williams MD
Assistant Professor of Psychiatry & Behavioral Science

STANFORD UNIVERSITY

David Wood
David Wood
Chief Legal Officer and General Counsel

PSYGEN INDUSTRIES LTD.

Berra Yazar-Kolinski Ph.D.
Berra Yazar-Kolinski Ph.D.
Chief Scientific Officer

MAPS PBC

TOP REASONS TO PURCHASE

  1. The POS is a mission driven event, designed to bring together key stakeholders from the investment, payer, provider, pharma, regulatory, scientific and medical communities to advance safe, affordable and effective access to psychedelic therapies.
  2. The POS brings together real-world practitioners with evidence based content to share.
  3. The POS is the only event designed to bring together investors, payers, providers, pharma to discuss psychedelics in behavioral therapy
  4. The POS brings together leading experts, medical professionals, scientists, entrepreneurs and embedded media
  5. There is no known event that fills the investor knowledge gap on this

WHO SHOULD PURCHASE

Titles:

  • Founder
  • Chief Executive Officer
  • Chief Medical Officer
  • Chief Science Officer
  • Chief Reasearch Officer
  • Chief Financial Officer
  • Chief Investment Officer
  • General Counsel
  • Executive Director
  • Managing Director
  • Partner
  • Principal
  • Entrepeneur

Head Of:

  • Research
  • CMC
  • Project Management
  • Regulatory Affairs
  • Billing
  • Clinical Trials
  • Strategy
  • Science
  • Development
  • Partnerships
  • Medical Affairs

Function:

  • Investment
  • Strategy
  • Research & Development
  • Finance
  • Innovation
  • Corporate Development
  • Medical Affairs

Industry:

  • Private Equity
  • Hedge Funds
  • Venture Capital
  • Insurance Companies
  • Hospital Systems
  • Pharma
  • Biotech
  • Clincal Trials
  • Legal

Sponsors

Supporting Sponsor

MEDIA PARTNERS

STATEMENT ON MEDICAL ADVICE: THE CONFERENCE, EVENT WEBSITE OR SPEAKERS MAY OFFER HEALTH, FITNESS, NUTRITIONAL AND OTHER SUCH INFORMATION, BUT SUCH INFORMATION IS DESIGNED FOR EDUCATIONAL AND INFORMATIONAL PURPOSES ONLY. THE INFORMATION CONTAINED ON THE SITE DOES NOT AND IS NOT INTENDED TO CONVEY MEDICAL ADVICE AND DOES NOT CONSTITUTE THE PRACTICE OF MEDICINE. YOU SHOULD NOT RELY ON THIS INFORMATION AS A SUBSTITUTE FOR, NOR DOES IT REPLACE, PROFESSIONAL MEDICAL ADVICE, DIAGNOSIS, OR TREATMENT. WE ARE NOT RESPONSIBLE FOR ANY ACTIONS OR INACTION ON A USER’S PART BASED ON THE INFORMATION THAT IS PRESENTED ON THE SITE.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. Privacy Policy

The cookie settings on this website are set to "allow cookies" to give you the best browsing experience possible. If you continue to use this website without changing your cookie settings or you click "Accept" below then you are consenting to this.

Close